{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Christe V"],"pubmed_abstract":["<h4>Background</h4>Changes in antihypertensive drug treatment are paramount in the adequate management of patients with hypertension, still, there is little information regarding changes in antihypertensive drug treatment in Switzerland. Our aim was to assess those changes and associated factors in a population-based, prospective study.<h4>Methods</h4>Data from the population-based, CoLaus study, conducted among subjects initially aged 35-75 years and living in Lausanne, Switzerland. 772 hypertensive subjects (371 women) were followed for a median of 5.4 years. Data Subjects were defined as continuers (no change), switchers (one antihypertensive class replaced by another), combiners (one antihypertensive class added) and discontinuers (stopped treatment). The distribution and the factors a"],"journal":["BMC pharmacology & toxicology"],"pagination":["20"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4021828"],"repository":["biostudies-literature"],"pubmed_title":["Antihypertensive drug treatment changes in the general population: the CoLaus study."],"pmcid":["PMC4021828"],"pubmed_authors":["Vollenweider P","Waeber G","Christe V","Marques-Vidal P"],"additional_accession":[]},"is_claimable":false,"name":"Antihypertensive drug treatment changes in the general population: the CoLaus study.","description":"<h4>Background</h4>Changes in antihypertensive drug treatment are paramount in the adequate management of patients with hypertension, still, there is little information regarding changes in antihypertensive drug treatment in Switzerland. Our aim was to assess those changes and associated factors in a population-based, prospective study.<h4>Methods</h4>Data from the population-based, CoLaus study, conducted among subjects initially aged 35-75 years and living in Lausanne, Switzerland. 772 hypertensive subjects (371 women) were followed for a median of 5.4 years. Data Subjects were defined as continuers (no change), switchers (one antihypertensive class replaced by another), combiners (one antihypertensive class added) and discontinuers (stopped treatment). The distribution and the factors a","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Mar","modification":"2025-04-19T02:41:16.686Z","creation":"2019-03-27T01:28:16Z"},"accession":"S-EPMC4021828","cross_references":{"pubmed":["24685255"],"doi":["10.1186/2050-6511-15-20"]}}